ABSTRACT
Since the first edition of this book was published there have been substantial
advances in the treatment of human immunodeficiency virus (HIV) infection and
the corollary acquired immunodeficiency syndrome (AIDS). Multiregimen
antiretroviral therapy has allowed HIV/AIDS to be managed in a manner that was
impossible in 1992. The development of successful treatments for HIV/AIDS and
the effectiveness of antimicrobials, trimethoprim/sulfamethoxazole or dapsone,
in the treatment of Pneumocystic carinii pneumonia (PCP) have reduced
pentamidine aerosol therapy to a second-line approach. However, this remains a
valuable therapy for treatment of PCP.
